Before taking early retirement on health grounds in 2007, Andrew Haynes, FRPharmS, was deputy editor of The Pharmaceutical Journal. As a freelance journalist, he continued to manage the weekly Onlooker/Last Word page until June 2014, and also contributed to the page regularly as both “Didapper" (from 2008) and “Bystander” (from 2009). He can be contacted via http://about.me/MrAndrewHaynes
A taste of his own medicine, by Linda Fawke
Editing The Pharmaceutical JournalSubscription
We, the undersigned, are pressing for the restoration of the post of editor for The Pharmaceutical Journal. We believe that the The Pharmaceutical Journal needs to be refocused and that the recent departure of its publisher presents an ideal opportunity to review the situation. One of us (Douglas Simpson) addressed the Royal Pharmaceutical Society’s (RPS) Assembly on this matter on 16 November 2016. However, no indication has been given about any of the Assembly’s dec
Celebrating 150 years of UK standards for drugs Subscription
‘The British pharmacopoeia, 1864 to 2014: medicines, international standards and the state’, by Anthony C Cartwright.
A physician’s insight into drug development Subscription
A new perspective on addictionSubscription
Farewell Graeme SmithSubscription
Caustic criticism for big business in healthcareSubscription
Assessing health adviceSubscription
Recent blog posts
Andrew Haynes describes the health risks — or lack of health risks — of popular Christmas plants.
A contributing factor to the rise of premature births and the early onset of puberty may be the use of the chemical BPA in plastic products.
Researchers in Mexico have raised the possibility of a new treatment for osteoporosis based on an extract from the plant that is the source of Mexico’s well known spirit drink, tequila.